Vaccination News

Cervical cancer is the fourth most common cancer among women, according to WHO. In 2018, it caused an estimated 311,000 deaths worldwide.

The CDC recently announced changes to its quarantine guidance. The agency now recommends that asymptomatic people with COVID-19 isolate for 5 days, followed by 5 days of mask wearing around others.

The FDA on Monday amended an emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine to add a booster dose for children aged 12 to 15 years, citing a need to protect them from the omicron variant.

Throughout the year, Healio has conducted exclusive interviews with physicians, researchers and policy experts to learn more about emerging research and other health care updates that impact clinical practice.

Although COVID-19 remained a popular topic among Healio Primary Care readers in 2021, other stories that discussed diabetes screening and physician suicide also generated significant attention.

Leading the top stories in infectious disease last week are two announcements from the FDA: the emergency use authorization of the first oral antiviral for COVID-19 and the approval of the first long-acting injectable for HIV prevention.

COVID-19 dominated the headlines in 2021, as doctors and patients alike feared its effects on pregnancy. Here are Healio’s top 10 stories about the intersection between the disease and reproductive health.

A COVID-19 vaccine for young children is “unlikely” to be available before mid or even late 2022, an expert said.

As of Dec. 1, the FDA had approved 46 novel drugs this year, one fewer than it had approved by the same date in 2020.

There have been rare reports of myocarditis and pericarditis among people who have received a COVID-19 messenger RNA vaccine, with cases occurring especially among male adolescents and young adults, according to the CDC.